Chief Executive Officer
Mr. Mullen is currently Chief Executive Officer of Patheon. He joined Patheon Inc. in 2011 as CEO and has continuously contributed to the company’s growth. Mr. Mullen led Patheon in 2012 as it acquired Banner Pharmacaps, a market leader in soft gelatin capsule technology. As a result of this acquisition, all of Banner’s manufacturing sites were structured under Patheon’s existing CMO business, aligning to the rest of its global network. In 2013, he led Patheon in a $2.6 billion transaction that merged Patheon with DSM Pharmaceutical Products, creating DPx. Mr. Mullen is also an Officer of DPx Holdings B.V.
Prior to joining Patheon, he served as CEO and President at Biogen Idec Inc. from 2003 to 2010, one of the world's largest biotechnology companies. Mr. Mullen was responsible for the merger of Biogen and Idec Pharmaceuticals, serving as CEO and President of Biogen from 2000 to 2002, and Chairman, CEO and President of Biogen until the merger was complete in 2003. Additionally, Mr. Mullen held various operating positions at Biogen prior to becoming CEO, including Vice President, Operations, and several manufacturing and engineering positions over a nine-year period at SmithKline Beecham.
Mr. Mullen possesses over 30 years of industry experience, ranging from biotechnology, pharmaceuticals to specialty chemicals, as well as extensive expertise in pharmaceutical and biotech manufacturing, engineering, sales, marketing, mergers and acquisitions. Currently, he serves on the Board of Directors for Perkins Elmer Inc. and as a trustee of The Rivers School. He previously served as Chairman of the Biotechnology Industry Organization. Mr. Mullen holds a Bachelor of Science in chemical engineering from Rensselaer Polytechnic Institute and a Master of Business Administration from Villanova University.